98450944
Mar 15, 2024
Therapeutic and prophylactic pharmaceutical products for use in the treatment of cancer, genetic diseases, rare diseases, neurodegenerative diseases and diseases of the immune system; pharmaceutical substances and preparations for use in the treatment of cancer, genetic diseases, rare diseases, neurodegenerative diseases and diseases of the immune system; enzymes and enzyme preparations for medical uses; vectors being gene therapy viral vectors or DNA plasmids for the delivery of genes to cells, all for medical purposes; genetically modified cells for medical use for the treatment of cancer, genetic diseases, rare diseases, neurodegenerative diseases and diseases of the immune system; vectors being gene therapy viral vectors or DNA plasmids for medical use; cell cultures, peptides, proteins, nucleic acids, modified nucleic acids, ribonucleotide protein, mRNA or complexes of these molecules for medical use.
PharmaceuticalsScientific, pharmaceutical and medical research and development in the field of gene modification, gene editing, gene correction, gene repair, gene modulation, cell therapy, cellular modification and gene therapy; genetic engineering services, biotechnology services, advisory services relating to cell therapy and gene therapy products; consultancy and advisory services relating to the aforesaid services.
Computer and Scientific